Kynam Capital Management, LP

10% Owner
Kynam Capital Management, LP
$334,977,000.00
%
COMPANY
SHARES
NET TOTAL
20.98%
GLOBAL BLOOD THERAPEUTICS IN
2,200,000
$70,290,000.00
14.43%
SYNDAX PHARMACEUTICALS INC
2,512,240
$48,335,000.00
13.11%
NATERA INC
1,239,047
$43,912,000.00
9.85%
CELLDEX THERAPEUTICS INC NEW
1,378,659
$33,002,000.00
8.93%
TRAVERE THERAPEUTICS INC
1,235,151
$29,928,000.00
4.81%
BIOGEN INC
78,951
$16,101,000.00
4.70%
VAXCYTE INC
723,781
$15,749,000.00
2.96%
BIOCRYST PHARMACEUTICALS INC
936,563
$9,909,000.00
2.89%
AMICUS THERAPEUTICS INC
900,000
$9,666,000.00
2.69%
COGENT BIOSCIENCES INC
1,000,000
$9,020,000.00
2.04%
VIRIDIAN THERAPEUTICS INC
590,143
$6,828,000.00
1.95%
LIQUIDIA CORPORATION
1,500,718
$6,543,000.00
1.78%
AMARIN CORP PLC
4,009,893
$5,975,000.00
1.65%
WAVE LIFE SCIENCES LTD
1,696,735
$5,514,000.00
1.59%
XENON PHARMACEUTICALS INC
175,000
$5,324,000.00
1.26%
CONCERT PHARMACEUTICALS INC
1,000,000
$4,210,000.00
0.70%
MERUS N V
103,627
$2,346,000.00
0.60%
FATE THERAPEUTICS INC
81,064
$2,009,000.00
0.58%
AFFIMED N V
701,029
$1,942,000.00
0.54%
AKOUOS INC
383,784
$1,800,000.00
0.49%
PUMA BIOTECHNOLOGY INC
579,915
$1,653,000.00
0.30%
OLEMA PHARMACEUTICALS INC
249,229
$1,014,000.00
0.28%
ALNYLAM PHARMACEUTICALS INC
50,000
$925,000.00
0.26%
SERES THERAPEUTICS INC
258,647
$887,000.00
0.19%
CONNECT BIOPHARMA HLDGS LTD
739,649
$643,000.00
0.17%
CABALETTA BIO INC
546,800
$580,000.00
0.17%
KARUNA THERAPEUTICS INC
38,900
$578,000.00
0.05%
CATALYST BIOSCIENCES INC
93,434
$166,000.00
0.04%
NEOLEUKIN THERAPEUTICS INC
124,701
$128,000.00